Urine Testing Cups Market Report Scope & Overview:

Urine Testing Cups Market size was valued at USD 1.42 billion in 2024 and is expected to reach USD 2.50 billion by 2032, growing at a CAGR of 7.42% over the forecast period of 2025-2032.

The demand for Urine Testing Cups Market is driven by the increasing incidences of chronic diseases, urinary tract infections, and the growing adoption of home diagnostics. Technological innovations, by the development of smart urine testing cups and the immunoassay technology in the cups, are making accuracy and convenience increasingly sought after. Moreover, the shift towards quick, non-invasive testing and digital integration is driving market growth in hospitals, laboratories, and home care settings globally.

For instance, in March 2025, Roche Diagnostics expanded its multi-parameter urine test cup portfolio in Europe and APAC, boosting home and clinical testing adoption.

Key Urine Testing Cups Market Trends

• Growing demand for home-based and point-of-care urine testing for convenience and rapid results.

• Smart urine testing cups with digital and IoT integration are driving technological innovation.

• Multi-parameter and immunoassay-based cups are increasingly adopted in hospitals and diagnostic labs.

• Rising prevalence of UTIs, kidney disorders, and chronic diseases is boosting test volumes globally.

• Expansion of diagnostic labs and outpatient clinics in APAC and Latin America to meet increasing demand.

• Shift toward AI-assisted, automated, and non-invasive urine testing for higher accuracy and efficiency.

Urine Testing Cups Market Report Highlights

The U.S. Urine Testing Cups Market was valued at USD 0.57 billion in 2024 and is expected to reach USD 1.00 billion by 2032, growing at a CAGR of 7.38% from 2025-2032. The Urine Testing Cups Market in the US is led by advanced healthcare infrastructure, high acceptance of home and point-of-care diagnostics, and the presence of a well-established clinical research network. Growth of UTI numbers, kidney diseases, and chronic ailments, and technology advancements, including smart and multi-parameter urine testing cups, strong reimbursement policies, and focus on consumerization, will continue to drive market growth and position in the region.

The Urine Testing Cups Market is increasing because of the increase in UTIs, chronic diseases, and home tests. Trends driving clinical market growth include smart, multi-parameter, and immunoassay-based cups, digital integration, and rapid, non-invasive testing, resulting in growing global adoption and market expansion.

Key Urine Testing Cups Market Segment Analysis

• By Product, with temperature strip held the largest share of around 62.52% in 2024, and the without temperature strip segment is expected to register the highest growth with a CAGR of 7.78%.

• By Application, the drug testing segment dominated the market with approximately 58.40% share in 2024, while disease detection is expected to register the highest growth with a CAGR of 9.02%.

• By Technology, visual test cups accounted for the leading share of nearly 32.85% in 2024, whereas smart urine testing cups are expected to register the highest growth with a CAGR of 9.39%.

• By End User, the hospitals & clinics segment led the market with about 60.22% share in 2024, while personal use is forecasted to grow the fastest at a CAGR of 12.22%.

By Product, With Temperature Strip Lead Market and Without Temperature Strip Register Fastest Growth

In 2024, the with temperature strip segment held a demanding revenue of around 62.52% in the Urine Testing Cups Market share and is expected to continue its dominance, owning with temperature strip checking, the urine testing cups can significantly increase the reliability of initial drug screening results by determining whether the urine is freshly provided. A urine sample should be at or around body temperature. The without temperature strip segment is projected to experience the fastest CAGR growth of around 7.78%, as consumers and physicians seek broad clinical and consumer adoption fueled by lower cost, ease of use, increased home test diagnoses, and demand for rapid multi-parameter urine testing.

By Application, Drug Testing Dominates and Disease Detection Shows Rapid Growth Over the Forecast Period

The interventional cardiology devices industry was dominated by the drug testing segment with a revenue share of over 58.40% in 2024, driven by strict workplace laws, soaring substance abuse screening, increased acceptance in hospitals and labs, and the ongoing need for rapid, dependable, and little-to-moderately priced urine testing kits globally. On the other hand, disease detection is anticipated to record the fastest CAGR of 9.02% during the forecast period (2024-2032), owing to the growing incidence of UTIs, kidney diseases, and diabetes, and rising home diagnostics usage, along with the need for rapid and multi-parameter testing in urine.

By Technology, Visual Test Cups Lead, Whereas Smart Urine Testing Cups Registers the Fastest Growth

The visual test cups segment led the interventional cardiology devices industry with the highest revenue market share of about 32.65% in 2024, owing to its demonstrable potential for lowering rates of restenosis and enhancing long-term results. Their successful use in the context of percutaneous coronary intervention (PCI), strong adoption, and ongoing development of drug-polymer combinations. The smart urine testing cups segment is likely to register the fastest CAGR of approximately 7.75% over the forecast years 2024-2032, due to greater use of provisional scaffolding, bioresorbable material progress, and lower long-term complications, together with a growing clinical confidence in safer novelty temporary metallic stent alternatives in the field of interventional cardiology.

By End User, Hospitals & ASCs Lead, and Grow the Fastest

The hospitals & clinics segment of the interventional cardiology devices industry was estimated as the highest earning segment with a revenue share of around 60.22% in 2024, owing to developed healthcare infrastructure, trained cardiologists, a large number of procedures, a favorable reimbursement scenario, and the adoption of integrated imaging devices to expedite patient care and lead the market. And projected to attain the highest CAGR of approximately 6.85% throughout the forecast period (2024-2032), owing to the growing number of outpatient cardiac procedures, growing adoption of ASCs, introduction of minimally invasive procedures, and the rising number of cath lab installations and increasing healthcare expenditure in emerging countries.

Asia Pacific Urine Testing Cups Market Insights

The Asia Pacific segment is projected to witness the fastest CAGR of 7.07% during the forecast period of 2024–2032, as there is an increasing prevalence of cardiovascular diseases, a geriatric population, and the incidence of diabetes and obesity. Increased healthcare infrastructure, government initiatives, and growing awareness regarding minimally invasive cardiac procedures further boost the adoption. Moreover, the growing spending by global device manufacturers, favourable reimbursement policies, and rapid expansion of catheterization labs in countries including China, India, and Japan further bolster the regional outlook.

North America Urine Testing Cups Market Insights

North America accounted for the highest revenue share of approximately 38.80% in 2024 of the Urine Testing Cups Market, owing to the well-established medical facilities, high incidence of CVDs, and heavy uptake of non-invasive techniques, comprising connections among PCI and TAVR. The presence of top global device manufacturers, huge R&D investments, and robust reimbursement systems will add to the market leadership. Furthermore, the strong awareness, presence of experienced cardiologists, and easy accessibility to advanced cardiac centers have further ensured that North America continues to lead the market.

Europe Urine Testing Cups Market Insights

The Europe Urine Testing Cups Market is growing steadily due to the increasing incidence of cardiovascular diseases, the growing geriatric population, and high penetration of minimally invasive procedures, including PCI and structural heart procedures. The market is driven by robust healthcare infrastructure, positive reimbursement policies, and established R&D efforts by key device manufacturers. Moreover, increased awareness, a rising number of cardiac centers, and early adoption of advanced technologies, including bioresorbable and drug-eluting stents, are also contributing to the large market share of Europe.

Latin America (LATAM) and Middle East & Africa (MEA) Urine Testing Cups Market Insights

The Middle East & Africa and Latin America markets are also increasing, owing to a higher risk of cardiovascular diseases, favorable government healthcare reforms, along with a growing number of low- and middle-income countries (LMICs) with a growing number of cardiac centers in the regions. The Middle East & Africa are a growing market, with a healthy cardiovascular disease patient pool, healthcare investments, a rise in dedicated cardiac centers, and greater use of PCI, TAVR, and other interventional devices.

Urine Testing Cups Market Growth Drivers:

• Rising Prevalence of Cardiovascular Diseases is Driving the Urine Testing Cups Market Growth

Rise in awareness of animal health is also one of the key factors for the growth of the Urine Testing Cups Market. Growth in pet owners’ concern regarding healthy nutrition, weight monitoring, and pets' well-being is driving the demand for automated feeders. With accurate portion control, purring schedules, and any monitoring, they are designed to allow owners to take care of their pets' health and obesity while also sharing their diets.

For instance, in April 2025, the increasing elderly population globally, especially in North America, Europe, and the Asia-Pacific, drives higher demand for interventional cardiology procedures.

Urine Testing Cups Market Restraints:

• Stringent Regulatory Approvals are Hampering the Urine Testing Cups Market Growth

The Urine Testing Cups Market is heavily dependent on the regularity clearance of the products, and due to its complex and time-consuming process across countries, the market faces some challenges to handle. For devices including drug-eluting stents (DES), bioresorbable scaffolds, and structural heart implants, extensive clinical trials and regulatory approval by the FDA, EMA, PMDA, among others, are required, which may cause long launch waits, high development costs, and market unavailability on time.

Urine Testing Cups Market Opportunities:

• Emerging Markets Expansion is a Significant Growth Opportunity in the Urine Testing Cups Market

The use of AI and machine learning in Interventional Cardiology Devices offers major potential, improving diagnostic accuracy, predictive analytics, and workflow. The firms’ institutions and care centers will gain an edge over competitors when they choose AI-driven imaging, as control over the Urine Testing Cups Market affects profit margins and hastens technology upgrades globally.

For instance, in March 2025Top of Form, rising cardiovascular disease and expanding cardiac centers in the Asia-Pacific are driving increased adoption of interventional cardiology procedures.

Competitive Landscape for Urine Testing Cups Market:

Boston Scientific Corporation (est. 1979, Massachusetts, USA): A global leader in coronary and peripheral stents, balloons, and structural heart devices, with a focus on innovative solutions for minimally invasive heart and vascular interventions.

• In February 2025, Boston Scientific launched the SYNERGY XD drug-eluting stent in Europe and expanded TAVR/MitraClip structural heart devices in the Asia-Pacific, enhancing coronary and minimally invasive procedure outcomes.

Medtronic plc (est. 1949, USA, Minnesota) Multi-national medical device company that designs, manufactures, and sells coronary and peripheral stents, guidewires, and catheter systems for endovascular therapy, and other cardiovascular devices, including heart valve systems.

• In March 2025, Medtronic introduced the IN. PACT Admiral drug-coated balloon in the U.S. and expanded robotic-assisted PCI systems across Europe and Latin America for precise cardiovascular interventions. 

Abbott Laboratories (est. 1888, Illinois, USA) Integrated healthcare company, focused on drug-eluting stents, vascular closure systems, and diagnostics, with leadership positions in interventional cardiology, and a commitment to continued innovation in the market.

• In January 2025, Abbott Laboratories received FDA approval for the XIENCE Skypoint DES for complex coronary lesions and launched new coronary and peripheral devices in emerging markets, improving global interventional cardiology access.

Urine Testing Cups Market Key Players:

Some of the Urine Testing Cups Market Companies

• Boston Scientific Corporation

• Medtronic plc

• Abbott Laboratories

• Edwards Lifesciences Corporation

• Terumo Corporation

• Siemens Healthineers

• Philips Healthcare

• Johnson & Johnson

• Cook Medical

• Becton Dickinson

• Cardinal Health

• MicroPort Scientific Corporation

• LivaNova PLC

• Merit Medical Systems, Inc.

• Sorin Group

• ABIOMED, Inc.

• Terumo Interventional Systems

• Claret Medical, Inc. 

• Neovasc Inc.

• Boston Scientific